Trials / Completed
CompletedNCT06048627
Anti-gingivitis Mouthrinse
Clinical Investigation to Assess the Efficacy of an Antimicrobial Mouthrinse in the Reduction of Established Plaque and Gingivitis: a 6-month Clinical Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Colgate Palmolive · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to prove whether a fluoride/zinc lactate containing mouthrinse is able to reduce dental plaque and gingival inflammation in patients who have gingivitis when applied twice daily during brushing at home over a period of 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amine/zinc lactate/fluoride system | Amine/zinc lactate/fluoride system (250 ppm F), meridol®, Colgate-Palmolive |
| DRUG | negative control | Sodium fluoride mouthwash 250 ppm |
Timeline
- Start date
- 2024-03-06
- Primary completion
- 2024-10-01
- Completion
- 2024-10-01
- First posted
- 2023-09-21
- Last updated
- 2025-05-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06048627. Inclusion in this directory is not an endorsement.